ACS Treatment (MONA-GAP-BA)

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/108

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 3:03 AM on 7/7/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

109 Terms

1
New cards

When should MONA drugs be given for ACS?

ASAP as needed (give first)

2
New cards
When should morphine be used in ACS?
Only for patients with unacceptable chest discomfort despite other treatments
3
New cards
Why is morphine not routinely used in ACS?
It may diminish antiplatelet effects
4
New cards

What is the dose of morphine for ACS?

2-5 mg IV repeated q5-30 min prn

5
New cards

What are the major adverse effects to monitor with morphine in ACS?

Hypotension, bradycardia, nausea/vomiting, sedation, and respiratory depression
6
New cards
When should oxygen be administered in ACS?
When SaO₂ <90% or the patient has respiratory distress
7
New cards
How do nitrates help treat ACS?

They dilate coronary arteries, improve collateral blood flow, decrease preload and afterload (modestly), and reduce chest pain

8
New cards
How should sublingual nitroglycerin be dosed in ACS?
0.4 mg every 5 minutes for up to 3 doses
9
New cards
When is IV nitroglycerin considered in ACS?
If chest pain or symptoms persist after sublingual nitroglycerin
10
New cards
When should nitroglycerin NOT be used?

SBP <90 mmHg

HR <50 bpm

right ventricular infarction

recent PDE-5 inhibitor use

11
New cards

When is ASA given in ACS?

immediately

12
New cards

What aspirin dose should be given immediately in ACS?

162–325 mg of non-enteric-coated chewable aspirin (if no contraindications)
13
New cards
What is the maintenance aspirin dose after ACS?
75–100 mg daily indefinitely
14
New cards

What can be used if a patient is intolerant to aspirin for ACS treatment?

Clopidogrel or ticagrelor
15
New cards

When are GAP drugs given in ACS treatment?

after MONA drugs, determined by plan

16
New cards

Name the GP IIb/IIIa receptor antagonists for ACS

Abciximab, eptifibatide, tirofiban
17
New cards
How do anticoagulants benefit patients with ACS?
They inhibit clotting factors and reduce infarct size
18
New cards
Which anticoagulants are commonly used in ACS?
LMWHs (enoxaparin, dalteparin), UFH, and bivalirudin (preferred for STEMI)
19
New cards
Name the P2Y12 inhibitors used in ACS
Clopidogrel, prasugrel, ticagrelor
20
New cards

When are BA drugs given in ACS treatment?

within 24 hours as needed and continued outpatient

21
New cards
How do beta-blockers benefit patients with ACS?

Decrease BP, HR, and contractility; decrease ischemia, reinfarction, and arrhythmias; prevent cardiac remodeling; improve long-term survival

22
New cards
When should beta-blockers be started after ACS?
Within the first 24 hours unless contraindicated
23
New cards
Which beta-blockers are preferred in ACS?

Beta-1 selective agents without intrinsic sympathomimetic activity

24
New cards

Which beta-blockers are preferred in patients with HFrEF after ACS?

Bisoprolol, metoprolol succinate, or carvedilol
25
New cards

What are alternatives to oral BBs in ACS treatment?

IV BB or oral long acting non-DHP CCB (diltiazem or verapamil)

26
New cards
When should ACE inhibitors be started after ACS?
Within the first 24 hours unless contraindicated
27
New cards
Which patients should continue an ACE inhibitor indefinitely after ACS?
Patients with LVEF <40%, hypertension, diabetes, or stable CKD
28
New cards
What are the benefits of ACE inhibitors in ACS?
Block angiotensin II production, prevent cardiac remodeling, and decrease preload and afterload
29
New cards

What is the alternative to ACEi in ACS treatment?

ARBs

30
New cards

Why should IV ACE inhibitors be avoided during the first 24 hours after ACS?

Increased risk of hypotension
31
New cards

Which medications should be avoided during hospitalization for ACS and why?

NSAIDs (except aspirin)

They increase the risk of mortality, reinfarction, hypertension, cardiac rupture, renal insufficiency, and heart failure

32
New cards

Which calcium channel blocker should be avoided in the acute setting of ACS and why?

Immediate-release nifedipine, increased risk of mortality

33
New cards
How does aspirin inhibit platelet aggregation?
It irreversibly inhibits COX-1 and COX-2, decreasing thromboxane A₂ (TXA₂) production
34
New cards
What does thromboxane A₂ (TXA₂) do?
It promotes platelet aggregation
35
New cards
How do P2Y12 inhibitors inhibit platelet aggregation?
They bind the platelet ADP (P2Y12) receptor, preventing ADP-mediated activation of the GPIIb/IIIa receptor complex
36
New cards
How do GPIIb/IIIa receptor antagonists inhibit platelet aggregation?
They block the platelet GPIIb/IIIa receptor, preventing fibrinogen binding and platelet aggregation
37
New cards
How do PAR-1 antagonists inhibit platelet aggregation?
They bind the PAR-1 receptor, preventing thrombin-mediated platelet aggregation
38
New cards
Which drugs are P2Y12 inhibitors?
Clopidogrel, prasugrel, ticagrelor, cangrelor
39
New cards
Which P2Y12 inhibitors are thienopyridines?
Clopidogrel and prasugrel
40
New cards
  1. Which P2Y12 inhibitor(s) are prodrugs?

  2. Which P2Y12 inhibitor(s) is NOT a prodrug?

  1. Clopidogrel and prasugrel

  2. Ticagrelor

41
New cards
  1. Which P2Y12 inhibitor(s) bind irreversibly to the P2Y12 receptor?

  2. Which P2Y12 inhibitor binds reversibly to the P2Y12 receptor?

  1. Clopidogrel and prasugrel

  2. Ticagrelor

42
New cards

What is dual antiplatelet therapy (DAPT) for ACS?

Aspirin plus a P2Y12 inhibitor

43
New cards
When should a P2Y12 inhibitor loading dose be given?
Prior to PCI or at the time of ACS diagnosis if PCI is not being performed
44
New cards
What follows the loading dose of a P2Y12 inhibitor?
A maintenance dose
45
New cards
Which drug class blocks the final common pathway of platelet aggregation?
GPIIb/IIIa receptor antagonists
46
New cards
Which receptor does thrombin activate to promote platelet aggregation?
PAR-1
47
New cards

Clopidogrel:

  1. what is the LD

  2. what is the MD

  3. exception

  1. 300-600 mg po (if PCI then 600 mg)

  2. 75 mg po daily

  3. patients who are >75 years old who had fibrinolytic therapy for STEMI do NOT need a loading dose, start on maintenance dose

48
New cards

Which enzyme is responsible for metabolizing Clopidogrel to its active form?

CYP2C19

49
New cards

Clopidogrel:

  1. contraindications

  2. warnings

  3. side effects

  1. active serious bleed

  2. bleed risk (stop 5 d before surg); dont use with omeprazole or esomeprazole, TTP

  3. generally none, unless bleeding occurs

50
New cards

Which P2Y12 inhibitor is only indicated for ACS managed with PCI?

Prasugrel (Effient)

51
New cards

Prasugrel (effient)

  1. LD

  2. MD

  3. exception

  1. 60 mg po <1 hr after PCI

  2. 10 mg po qd + ASA

  3. MD of 5 mg qd if patient weighs <60 kg

52
New cards
How should prasugrel be stored?
Protect from moisture and dispense in the original container
53
New cards
What is the boxed warning for prasugrel?

Significant, sometimes fatal, bleeding

not rec for patients ≥75 years old unless they are high risk (diabetes or prior MI)

must stop 7 days before elective surgery

54
New cards
What are the contraindications to prasugrel?
Active serious bleeding and history of TIA or stroke
55
New cards
What are the warnings for prasugrel?
Bleeding risk, premature discontinuation (↑ thrombosis risk), and thrombotic thrombocytopenic purpura (TTP)
56
New cards
What is the major side effect of prasugrel?
Bleeding (higher risk than clopidogrel)
57
New cards

Ticagrelor (Brilinta):

  1. LD

  2. MD

  1. 180 mg

  2. 90 mg po BID x 1 year then 60 mg BID

58
New cards
How can ticagrelor tablets be administered if the patient cannot swallow them?
Crushed and mixed with water for oral or NG tube administration
59
New cards
What is the boxed warning for ticagrelor?
Significant, sometimes fatal, bleeding
60
New cards

What aspirin maintenance dose should NOT be exceeded with ticagrelor and why?

100 mg/day; Higher aspirin doses reduce ticagrelor effectiveness

61
New cards
When should ticagrelor be avoided before surgery?
If CABG is likely, stop at least 5 days before surgery
62
New cards
What are the contraindications to ticagrelor?
Active serious bleeding and history of intracranial hemorrhage
63
New cards
What are the warnings for ticagrelor?
Bleeding risk, severe hepatic impairment, bradyarrhythmias, premature discontinuation (↑ thrombosis risk), and TTP
64
New cards
What are the major side effects of ticagrelor?
Bleeding, dyspnea (>10%), increased serum creatinine, and increased uric acid
65
New cards
Which P2Y12 inhibitor is given intravenously?
Cangrelor
66
New cards
When is cangrelor indicated?
As an adjunct to PCI in P2Y12 inhibitor-naïve patients not receiving a GPIIb/IIIa inhibitor
67
New cards
What is the dosing regimen for cangrelor?
30 mcg/kg IV bolus before PCI, then 4 mcg/kg/min infusion for 2 hours or the duration of PCI (whichever is longer)
68
New cards

Canagrelor:

  1. CI

  2. SE

  1. Significant active bleeding

  2. bleeding

69
New cards
How long do cangrelor's effects last after discontinuation?
About 1 hour
70
New cards
What should patients receive after cangrelor is discontinued?
Transition to an oral P2Y12 inhibitor after PCI
71
New cards
What is the major drug interaction concern with P2Y12 inhibitors?
Additive bleeding risk with other medications
72
New cards
Which medications increase bleeding risk when combined with P2Y12 inhibitors?
NSAIDs, warfarin, SSRIs, and SNRIs
73
New cards
Should P2Y12 inhibitors be discontinued if bleeding occurs after ACS?
No, if possible manage bleeding without stopping the P2Y12 inhibitor because early discontinuation increases cardiovascular events
74
New cards

Which PPIs should be avoided with clopidogrel and why?

Omeprazole and esomeprazole; They inhibit CYP2C19 and decrease clopidogrel's antiplatelet effect

75
New cards

Which P2Y12 inhibitor is a major CYP3A4 substrate? and which drugs should be avoided when taking?

Ticagrelor; Strong CYP3A4 inhibitors and strong CYP3A4 inducers

76
New cards
Which statins should be limited to ≤40 mg/day with ticagrelor?
Simvastatin and lovastatin
77
New cards
Which medication should be monitored when starting or changing ticagrelor?
Digoxin
78
New cards
Which diabetes medication has increased effects with clopidogrel?

Repaglinide (Increased risk of hypoglycemia)

79
New cards

Which GPIIb/IIIa receptor antagonists reversibly block the GPIIb/IIIa receptor?

Eptifibatide and tirofiban
80
New cards

Which GPIIb/IIIa receptor antagonist irreversibly blocks the GPIIb/IIIa receptor?

Abciximab
81
New cards

When can eptifibatide and tirofiban be used for ACS treatment?

Medical management of ACS or patients receiving PCI ± stent
82
New cards

When is abciximab indicated for ACS treatment?

Only for PCI ± stent
83
New cards
What medication is given with a GPIIb/IIIa receptor antagonist during PCI?
Heparin
84
New cards

When is abciximab not recommended for ACS treatment?

Medical management of NSTE-ACS without PCI
85
New cards
What are the contraindications to GPIIb/IIIa receptor antagonists?
Thrombocytopenia, history of bleeding diathesis, active internal bleeding, severe uncontrolled hypertension, recent major surgery or trauma, and recent stroke or history of hemorrhagic stroke (eptifibatide)
86
New cards
What are the major side effects of GPIIb/IIIa receptor antagonists?
Bleeding and thrombocytopenia
87
New cards
What administration precaution should be followed with eptifibatide and tirofiban?
Do not shake the vials
88
New cards
When does platelet function return after stopping eptifibatide or tirofiban?
Approximately 4–8 hours
89
New cards
What is vorapaxar indicated for?
Patients with a history of MI or peripheral arterial disease (PAD) to reduce thrombotic cardiovascular events
90
New cards
What antiplatelet therapy was vorapaxar used with in clinical trials?
Aspirin and/or clopidogrel
91
New cards
What is the dose of vorapaxar?
2.08 mg (1 tablet) PO daily
92
New cards
What is the boxed warning for vorapaxar?
Bleeding risk (including intracranial hemorrhage and fatal bleeding)
93
New cards
When should vorapaxar NOT be used?
History of stroke, TIA, intracranial hemorrhage, or active serious bleeding
94
New cards
What warning is associated with vorapaxar?
Do not use in severe liver impairment
95
New cards
What are the major side effects of vorapaxar?
Bleeding and anemia
96
New cards
What is the major drug interaction with vorapaxar?
It is a CYP3A4 substrate and a P-gp inhibitor
97
New cards
Which medications should be avoided with vorapaxar?
Strong CYP3A4 inhibitors and strong CYP3A4 inducers
98
New cards
How do fibrinolytics work?
They bind to fibrin and convert plasminogen to plasmin, causing fibrinolysis (clot breakdown)
99
New cards
Which type of ACS are fibrinolytics used for?
STEMI only
100
New cards
When should fibrinolytic therapy be given for STEMI?

When PCI is not available and there are no contraindications;

Within 30 minutes of hospital arrival (door-to-needle time)